However, they did not test whether conditional deletion of Lin28b in fetal progenitors potentiates AML initiation, as one would expect if it were the sole effector of fetal protection, nor did they test whether LIN28B could impede the growth of fully transformed AML cells. The gene discussed is LIN28B; the disease is acute myeloid leukemia.